¶ 1 Leave a comment on paragraph 1 0 [et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”on” featured_placement=”background” parallax_effect=”off” parallax_method=”on” text_orientation=”right” text_color=”light” text_background=”on” text_bg_color=”rgba(21,150,137,0.9)” module_bg_color=”rgba(255,255,255,0)” title_font=”|on|||” title_font_size=”35px” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_id=”header-image-and-text”]
¶ 2 Leave a comment on paragraph 2 0
¶ 3 Leave a comment on paragraph 3 0 [/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section admin_label=”Seksjon” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Rad”][et_pb_column type=”2_3″][et_pb_text admin_label=”Tekst” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
Norwegian Cancer Genomics Consortium (NCGC) consists of clinicians and specialised cancer research groups, situated at the Norwegian University Hospitals. The participants collaborate on two large research projects, focused on cancer genomics. The projects, which have received 75 M NOK in funding from the Norwegian Research Council, aim to establish new clinical practises for cancer treatment. The projects are led by the associated group leaders, Tom Dønnem (UNN), Bjørn Tore Gjertsen (HUS), Jutta Heix (Oslo Cancer Cluster), Harald Holte (OUS), Eivind Hovig (OUS), Ragnhild Lothe (OUS), Per Eystein Lønning (HUS), Leonardo Meza-Zepeda (OUS), Ola Myklebost (OUS), Sissel Rogne (Bioteknologirådet), Ole Morten Seternes (UiT), Jan Helge Solbakk (UiO, vara Sissel Rogne), Giske Ursin (KR), Anders Waage (St Olav). Eyrun Thune is the coordinator.
¶ 4 Leave a comment on paragraph 4 0 [/et_pb_text][/et_pb_column][et_pb_column type=”1_3″][et_pb_text admin_label=”Contacts (title)” background_layout=”dark” text_orientation=”left” background_color=”#108271″ use_border_color=”off” border_color=”#ffffff” border_style=”solid” text_line_height=”2em” custom_padding=”10px|5px|5px|5px”]
Contacts
¶ 5 Leave a comment on paragraph 5 0 [/et_pb_text][et_pb_text admin_label=”Contacts” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 6
Leave a comment on paragraph 6 0
Ola Myklebost
Professor, Project leader
¶ 8 Leave a comment on paragraph 8 0 ola@kreftgenomikk.no
+47 5558 4565
¶ 10 Leave a comment on paragraph 10 0
¶ 11
Leave a comment on paragraph 11 0
Liv Cecilie Vestrheim Thomsen
Co-ordinator
¶ 13 Leave a comment on paragraph 13 0 liv@kreftgenomikk.no
+47 909 35 449
¶ 15 Leave a comment on paragraph 15 0 [/et_pb_text][et_pb_divider admin_label=”Skillelinje” color=”#ffffff” show_divider=”off” divider_style=”solid” divider_position=”top” hide_on_mobile=”on”]
¶ 16 Leave a comment on paragraph 16 0
¶ 17 Leave a comment on paragraph 17 0 [/et_pb_divider][et_pb_text admin_label=”The Project Leadership (title)” background_layout=”dark” text_orientation=”left” background_color=”#108271″ use_border_color=”off” border_color=”#ffffff” border_style=”solid” text_line_height=”1.9em” custom_padding=”10px|5px|5px|5px”]
The Governing Board
¶ 18 Leave a comment on paragraph 18 0 [/et_pb_text][et_pb_text admin_label=”The Project Leadership” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
Erlend B Smeland
¶ 19 Leave a comment on paragraph 19 0 Professor, Forskningsdriektør OUS, – Styreleder
¶ 20 Leave a comment on paragraph 20 0
Jónas Einarsson
¶ 21 Leave a comment on paragraph 21 0 Direktør Radiumhospitalets forskningsstiftelse
¶ 22 Leave a comment on paragraph 22 0
Anne Sameline Grimsgaard
¶ 23 Leave a comment on paragraph 23 0 Professor, Forskningsdekan UNN/UiT
¶ 24 Leave a comment on paragraph 24 0
Bjørn Gustafsson
¶ 25 Leave a comment on paragraph 25 0 Professor, Forskningsdekan StOlav/NTNU
¶ 26 Leave a comment on paragraph 26 0
Tove Flem Jacobsen
¶ 27 Leave a comment on paragraph 27 0 VP Science & Regulatory at Aker BioMarine Antarctic
¶ 28 Leave a comment on paragraph 28 0
Edvin W Johannesen
¶ 29 Leave a comment on paragraph 29 0 Seniorrådgiver – Forskningsadministrasjon UiO
¶ 30 Leave a comment on paragraph 30 0
Olav Mella
¶ 31 Leave a comment on paragraph 31 0 Professor, Avdelingssjef Haukeland/UiB
¶ 32 Leave a comment on paragraph 32 0
Knut Martin Torgersen
¶ 33 Leave a comment on paragraph 33 0 Medisinsk rådgiver Pfizer
¶ 34 Leave a comment on paragraph 34 0 [/et_pb_text][et_pb_text admin_label=”Partners” background_layout=”dark” text_orientation=”left” background_color=”#108271″ use_border_color=”off” border_color=”#ffffff” border_style=”solid” text_line_height=”1.9em” custom_padding=”10px|5px|5px|5px”]
Health service priority area
¶ 35 Leave a comment on paragraph 35 0 [/et_pb_text][et_pb_image admin_label=”Bilde” src=”http://kreftgenomikk.no/files/2013/11/logo.png” show_in_lightbox=”off” url=”http://kreftsatsing.no” url_new_window=”on” use_overlay=”off” animation=”off” sticky=”off” align=”left” force_fullwidth=”off” always_center_on_mobile=”on” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 36 Leave a comment on paragraph 36 0
¶ 37 Leave a comment on paragraph 37 0 [/et_pb_image][/et_pb_column][/et_pb_row][/et_pb_section]